Compare Lustrum:Medrx Co.,Ltd.:4586

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Medrx Co.,Ltd. Go to web site 4586 Medicals 東証グロース December 1, 2000 2013.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Medrx Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Medrx Co.,Ltd. Balance Sheet 2023年12月期 Medrx Co.,Ltd. Balance Sheet 2022年12月期 Medrx Co.,Ltd. Balance Sheet 2021年12月期 Medrx Co.,Ltd. Balance Sheet 2020年12月期 Medrx Co.,Ltd. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents
(Percent)
1,721up
(83.8%)up
994down
(71.1%)down
1,704down
(80.8%)up
1,812up
(78.9%)up
1,411
(68.9%)
Other Current AssetsHelp
(Percent)
64down
(3.1%)down
93up
(6.7%)up
51down
(2.4%)down
75down
(3.2%)down
90
(4.4%)
Tangible Fixed AssetsHelp
(Percent)
182down
(8.8%)down
226down
(16.2%)up
270down
(12.8%)down
328down
(14.3%)down
471
(23.0%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
34
(1.7%)
Investments and OthersHelp
(Percent)
86up
(4.2%)down
85up
(6.1%)up
83up
(4.0%)up
82up
(3.6%)up
41
(2.0%)
Total AssetsHelp
(Percent)
2,052
(100%)
1,398
(100%)
2,109
(100%)
2,297
(100%)
2,048
(100%)
Total Current LiabilitiesHelp
(Percent)
128down
(6.2%)down
186up
(13.3%)up
153up
(7.3%)up
150up
(6.5%)up
127
(6.2%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
1,925up
(93.8%)up
1,213down
(86.7%)down
1,955down
(92.7%)down
2,147up
(93.5%)down
1,921
(93.8%)
Total LiabilitiesHelp
(Percent)
2,052
(100%)
1,398
(100%)
2,109
(100%)
2,297
(100%)
2,048
(100%)

Medrx Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Medrx Co.,Ltd. Profit and Loss Account 2023年12月期 Medrx Co.,Ltd. Profit and Loss Account 2022年12月期 Medrx Co.,Ltd. Profit and Loss Account 2021年12月期 Medrx Co.,Ltd. Profit and Loss Account 2020年12月期 Medrx Co.,Ltd. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales
(Percent)
30
(100%)
59
(100%)
8
(100%)
115
(100%)
170
(100%)
Total Sales
(Percent)
30
(100%)
59
(100%)
8
(100%)
115
(100%)
170
(100%)
Cost of SalesHelp
(Percent)
2down
(8.1%)up
3up
(4.4%)down
2down
(27.1%)up
4down
(3.4%)up
5
(3.1%)
Other Costs and RevenueHelp 960down
(3,250.6%)up
1,168up
(1,963.6%)down
1,066down
(12,765.5%)up
1,226down
(1,065.1%)up
1,781
(1,048.5%)
Total CostsHelp 962 1,171 1,068 1,230 1,786
Net RevenueHelp 27down
(91.9%)down
57up
(95.6%)up
6down
(72.9%)down
111down
(96.6%)down
165
(96.9%)
Earnings Before TaxHelp -930up
(-3,149.2%)down
-1,109down
(-1,865.0%)up
-1,058up
(-12,676.3%)down
-1,107up
(-961.5%)down
-1,611
(-948.7%)
Net IncomeHelp -933up
(-3,158.7%)down
-1,111down
(-1,868.0%)up
-1,060up
(-12,692.6%)down
-1,115up
(-968.5%)down
-1,616
(-951.6%)
当期純利益 -933 -1,111 -1,060 -1,115 -1,616

Medrx Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Medrx Co.,Ltd. Cash Flow Statement 2023年12月期 Medrx Co.,Ltd. Cash Flow Statement 2022年12月期 Medrx Co.,Ltd. Cash Flow Statement 2021年12月期 Medrx Co.,Ltd. Cash Flow Statement 2020年12月期 Medrx Co.,Ltd. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-914up
(-55.7%)up
-1,073down
(-99.8%)down
-924up
(-99.7%)down
-985up
(-70.7%)up
-1,547
(-86.0%)
Investing Cash Flow(ICF)Help
(Percent)
-1up
(0.0%)up
-2up
(-0.2%)up
-3up
(-0.3%)up
-5up
(-0.4%)up
-252
(-14.0%)
Financing Cash FlowHelp
(Percent)
1,639up
(99.9%)up
356down
(33.1%)down
816down
(88.1%)down
1,394
(100.0%)up
1,394
(77.5%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
2down
(0.1%)down
9up
(0.9%)up
2up
(0.2%)up
-2down
(-0.1%)down
20
(1.1%)
Net Increase and Decrease in Cash and Cash Equivalentsn 727up
(44.3%)up
-710down
(-66.0%)down
-109down
(-11.7%)down
402up
(28.8%)up
-386
(-21.5%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Medrx Co.,Ltd.

Company where related level is highHelp

NIPPON CHEMIPHAR CO.,LTD.
OncoTherapy Science,Inc.
Takeda Pharmaceutical Company Limited
CanBas Co.,Ltd.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
NANO MRNA Co., Ltd.
MIKASA SEIYAKU CO.,LTD.
Mochida Pharmaceutical Co.,Ltd.
R-TECH UENO,LTD.
GNI Group Ltd.